245 related articles for article (PubMed ID: 690183)
21. Pancreatic polypeptide release: role of stimulants of exocrine pancreatic secretion in dogs.
Beglinger C; Taylor IL; Grossman MI; Solomon TE
Gastroenterology; 1984 Sep; 87(3):530-6. PubMed ID: 6146550
[TBL] [Abstract][Full Text] [Related]
22. Cholecystokinin in the control of gastric acid and plasma gastrin and somatostatin secretion in healthy subjects and duodenal ulcer patients before and after eradication of Helicobacter pylori.
Konturek JW
J Physiol Pharmacol; 1994 Dec; 45(4 Suppl 1):3-66. PubMed ID: 7787215
[TBL] [Abstract][Full Text] [Related]
23. Effect of beta-casomorphins on somatostatin release in dogs.
Schusdziarra V; Schick R; de la Fuente A; Holland A; Brantl V; Pfeiffer EF
Endocrinology; 1983 Jun; 112(6):1948-51. PubMed ID: 6133741
[TBL] [Abstract][Full Text] [Related]
24. Fundic inhibition of acid secretion and gastrin release in the dog.
Soon-Shiong P; Debas HT
Gastroenterology; 1980 Nov; 79(5 Pt 1):867-72. PubMed ID: 7419010
[TBL] [Abstract][Full Text] [Related]
25. Effect of gastrin-releasing peptide (GRP1-27), neuromedin-C (GRP18-27), and neuromedin-B on gastrin and somatostatin secretion from the rat stomach.
Madaus S; Schusdziarra V; Seufferlein T; Classen M
Z Gastroenterol; 1989 Sep; 27(9):449-54. PubMed ID: 2573979
[TBL] [Abstract][Full Text] [Related]
26. Sympathetic nerve stimulation versus pancreatic norepinephrine infusion in the dog: 2). Effects on basal release of somatostatin and pancreatic polypeptide.
Ahrén B; Veith RC; Paquette TL; Taborsky GJ
Endocrinology; 1987 Jul; 121(1):332-9. PubMed ID: 2885175
[TBL] [Abstract][Full Text] [Related]
27. Contribution of the pancreas to circulating somatostatin-like immunoreactivity in the normal dog.
Taborsky GJ; Ensinck JW
J Clin Invest; 1984 Jan; 73(1):216-23. PubMed ID: 6140271
[TBL] [Abstract][Full Text] [Related]
28. Opposing actions of glucagon and insulin on splanchnic d cell function.
Kawai K; Unger RH
J Clin Invest; 1983 Mar; 71(3):721-5. PubMed ID: 6131079
[TBL] [Abstract][Full Text] [Related]
29. Release of immunoreactive somatostatin from the pancreas in response to glucose, amino acids, pancreozymin-cholecystokinin, and tolbutamide.
Ipp E; Dobbs RE; Arimura A; Vale W; Harris V; Unger RH
J Clin Invest; 1977 Sep; 60(3):760-5. PubMed ID: 330567
[TBL] [Abstract][Full Text] [Related]
30. [The effects of selective proximal gastric vagotomy on antral mucosal gastrin and somatostatin concentrations].
Wanifuchi T
Nihon Geka Gakkai Zasshi; 1984 May; 85(5):433-44. PubMed ID: 6146924
[TBL] [Abstract][Full Text] [Related]
31. Gastric A-cell function in normal dogs.
Muñoz-Barragan L; Blazquez E; Patton GS; Dobbs RE; Unger RH
Am J Physiol; 1976 Oct; 231(4):1057-61. PubMed ID: 984193
[TBL] [Abstract][Full Text] [Related]
32. Characterization of the responses of circulating glucagon-like immunoreactivity to intraduodenal and intravenous administration of glucose.
Unger RH; Ohneda A; Valverde I; Eisentraut AM; Exton J
J Clin Invest; 1968 Jan; 47(1):48-65. PubMed ID: 5638120
[TBL] [Abstract][Full Text] [Related]
33. Response of plasma somatostatin-like immunoreactivity to the administration of alloxan in dogs.
Schusdziarra V; Harris V; Unger R
Horm Metab Res; 1979 Aug; 11(8):457-9. PubMed ID: 499995
[TBL] [Abstract][Full Text] [Related]
34. Adrenergic and cholinergic interactions in rat gastric somatostatin and gastrin release.
Koop H; Behrens I; Bothe E; McIntosh CH; Pederson RA; Arnold R; Creutzfeldt W
Digestion; 1982; 25(2):96-102. PubMed ID: 6129170
[TBL] [Abstract][Full Text] [Related]
35. Effect of 2-deoxy-D-glucose on plasma somatostatin levels in conscious dogs.
Wasada T; Dobbs RE; Harris V; Unger RH
Endocrinology; 1981 Apr; 108(4):1222-7. PubMed ID: 6110537
[TBL] [Abstract][Full Text] [Related]
36. Studies on the inhibition of pancreatic secretion by luminal somatostatin.
Konturek SJ; Tasler J; Cieszkowski M; Jaworek J; Arimura A; Schally AV
Am J Physiol; 1981 Aug; 241(2):G109-15. PubMed ID: 6115584
[TBL] [Abstract][Full Text] [Related]
37. Plasma levels of somatostatin following a test meal in dogs. Initial atropine resistant vagally mediated decrease of somatostatin levels and increase of gastrin and insulin levels.
Uvnäs-Moberg K; Andersson B; Posloncec B
Acta Physiol Scand; 1982 Feb; 114(2):253-9. PubMed ID: 6127867
[TBL] [Abstract][Full Text] [Related]
38. Plasma somatostatin response in normal and gastrectomized subjects.
Wasada T; Kodama Y; Inoue K; Hisatomi A; Sako Y; Ibayashi H
Tohoku J Exp Med; 1986 Oct; 150(2):181-8. PubMed ID: 2880412
[TBL] [Abstract][Full Text] [Related]
39. Modulatory effect of glucose, amino acids, and secretin on CCK-8-induced somatostatin and pancreatic polypeptide release in dogs.
Schusdziarra V; Lenz N; Schick R; Maier V
Diabetes; 1986 May; 35(5):523-9. PubMed ID: 2869995
[TBL] [Abstract][Full Text] [Related]
40. Effect and mechanism of vagal nerve stimulation on somatostatin secretion in dogs.
Ahrén B; Paquette TL; Taborsky GJ
Am J Physiol; 1986 Feb; 250(2 Pt 1):E212-7. PubMed ID: 2869692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
